An international consortium of pediatric oncology experts has published consensus guidelines on radiation treatment for children with metastatic rhabdomyosarcoma (RMS), offering site-specific ...
Regulatory clearance creates an at-home, 28-day cycle option using oral decitabine/cedazuridine on days 1–5 plus venetoclax 400 mg daily after a ramp-up cycle. Efficacy signals in ASCERTAIN-V included ...
Formal adoption of PMOS replaces a cyst-centric label with terminology capturing endocrine, metabolic, and ovarian dysfunction that drives infertility, menstrual irregularity, and long-term ...
Food insecurity identification modeling for Medicare can establish a reliable method of prioritizing members at risk of food ...
RBM20 truncating variants ( RBM20 tvs) appear to contribute to arrhythmogenic dilated cardiomyopathy (DCM) but with ...
Accelerated approval covers post–BTK inhibitor relapsed/refractory MCL, making sonrotoclax the only BCL2 inhibitor specifically approved for this indication. Independent Lugano-assessed efficacy in ...
In part 2 of her interview with The American Journal of Managed Care®, Deborah Doroshow, MD, PhD, assistant professor of ...
Women with endometriosis have an elevated risk of developing epithelial ovarian cancer, but, when they do develop it, they ...
Placebo-controlled evidence across 9013 patients showed a lower composite risk (HR 0.85) driven by reduced worsening HF ...
Anton M. Kolomeyer, MD, PhD, a retina specialist at NJRetina, spoke with The American Journal of Managed Care ® about ...
Young adults with early-onset colorectal cancer (EOCRC), particularly men and non-Hispanic Black and American Indian/Alaskan ...
Scott Shannon, MD, discusses psychedelic therapies, federal policy shifts, and the barriers slowing mental health innovation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results